2026-08-03T13:26:25-05:00 2025-12-31 871353108 EISNER ADVISORY GROUP LLC 733 THIRD AVENUE NEW YORK NY 100172703 990 2025-01-01 383110993 SEPSIS ALLIANCE INC SEPS 6192320300 3180 UNIVERSITY AVENUE STE 310 SAN DIEGO CA 92104 THOMAS N HEYMANN CHIEF EXECUTIVE OFFICER 6192320300 2026-08-03 1 WILLIAM EPSTEIN P01307171 2129498700 2025 2025-03-06 01:10:19Z THOMAS N HEYMANN 3180 UNIVERSITY AVENUE SAN DIEGO CA 92104 5604121 0 X WWW.SEPSIS.ORG X 2007 MI TO SAVE LIVES AND REDUCE SUFFERING BY EDUCATING THE PUBLIC (CONTINUED ON SCHED O) (CONTINUED FROM PG 1, PART 1, LINE 1) AND LEADING AN ALLIANCE OF PATIENTS, HEALTHCARE PROFESSIONALS, AND PARTNERS COMMITTED TO PREVENTING AND CURING SEPSIS. 19 16 14 50 0 0 2506949 5568712 0 0 29476 19345 11346 9170 2547771 5597227 0 0 0 0 1713598 1770721 0 0 367795 880965 1038403 2594563 2809124 -46792 2788103 1233473 3959171 244672 181338 988801 3777833 X TO SAVE LIVES AND REDUCE SUFFERING BY EDUCATING THE PUBLIC AND LEADING AN ALLIANCE OF PATIENTS, HEALTHCARE PROFESSIONALS, AND PARTNERS COMMITTED TO PREVENTING AND CURING SEPSIS. 0 0 721707 6393 PUBLIC AWARENESS AND EDUCATION & SUPPORTSEPSIS ALLIANCE CONTINUED TO EXPAND ITS REACH THROUGH SEPSIS.ORG, WHICH SERVED OVER 1.5 MILLION VISITORS WITH UPDATED AND MULTILINGUAL RESOURCES. THE ORGANIZATION LAUNCHED SEVERAL TARGETED CAMPAIGNS, INCLUDING THE GET VAXXED VACCINE CONFIDENCE CAMPAIGN AND AN ADDITIONAL CAMPAIGN WHICH ADDRESSED INFECTION PREVENTION FOR CANCER PATIENTS. THESE EFFORTS WERE SUPPORTED BY GRANTS FROM GLAXOSMITHKLINE AND ASTRAZENECA. ON A NATIONAL LEVEL, SEPSIS AWARENESS INCREASED TO 75%, A 9% INCREASE OVER 2024 AND A NEW HIGH, ACCORDING TO THE ANNUAL SEPSIS ALLIANCE AWARENESS SURVEY. SEPSIS ALLIANCE CONNECT GREW TO OVER 8,000 MEMBERS, OFFERING MORE THAN 150 LIVE VIRTUAL SUPPORT SESSIONS AND 14 NEW ON-DEMAND EDUCATIONAL PROGRAMS. (CONTINUED ON SCHED O)(CONTINUED FROM PART III, 4A) THE PLATFORM OFFERS AFFINITY GROUPS FOR YOUNG ADULTS, AMPUTEE SURVIVORS, AND THOSE WITH INVISIBLE DISABILITIES AFTER SEPSIS, AND CONTINUES TO EXPAND ITS EDUCATIONAL AND RESOURCE OFFERINGS. CONTINUED SUPPORT FOR THIS PROGRAM'S EDUCATIONAL OFFERINGS CAME FROM MERCK. 897219 PROFESSIONAL EDUCATION AND TRAINING SEPSIS ALLIANCE INSTITUTE (SAI) EXPERIENCED A 20.2% INCREASE IN USERS, REACHING OVER 69,900 LEARNERS. IT DELIVERED MORE THAN 179,000 REGISTERED NURSE (RN) CONTINUING EDUCATION CREDITS AND ADDED 25 NEW COURSES. THE ORGANIZATION HOSTED MULTIPLE HIGH-IMPACT EVENTS, INCLUDING THE SEPSIS ALLIANCE ANTIMICROBIAL RESISTANCE (AMR) CONFERENCE AND THE AMERICAN ASSOCIATION OF CRITICAL-CARE NURSES NATIONAL TEACHING INSTITUTE & CRITICAL CARE EXPOSITION (AACN NTI) AND EXPO HALL ACTIVITIES, AND THE SEPSIS ALLIANCE SYMPOSIUM: HEALTHCARE-ASSOCIATED INFECTIONS. THE SIXTH ANNUAL SEPSIS ALLIANCE SUMMIT DREW OVER 2,500 REGISTRANTS. PEER-TO-PEER ENGAGEMENT ALSO GREW, WITH A 28% INCREASE IN DISCUSSION RESPONSES (CONTINUED ON SCHED O)(CONTINUED FROM PART III, 4B) AND AN 18.3% INCREASE IN RESOURCE DOWNLOADS. IN 2025, SEPSIS ALLIANCE ALSO BECAME AN ACCREDITED PROVIDER TO THE ACCREDITATION COUNCIL FOR CONTINUING MEDICAL EDUCATION (ACCME) WHICH ALLOWS SAI TO OFFER CONTINUING EDUCATION CREDITS TO PHYSICIANS. 212739 POLICY AND ADVOCACYIN 2025, SEPSIS ALLIANCE EXPANDED ITS ADVOCACY EFFORTS AT BOTH THE FEDERAL AND STATE LEVELS TO IMPROVE SEPSIS AWARENESS, EARLY RECOGNITION, AND PATIENT OUTCOMES. THE ORGANIZATION SUPPORTED KEY FEDERAL LEGISLATION RELATED TO SEPSIS, DIAGNOSTICS, AND ANTIMICROBIAL RESISTANCE, WHILE ALSO ADVANCING THE STOP SEPSIS ACT IN NEW JERSEY TO STRENGTHEN HOSPITAL SEPSIS PROTOCOLS AND REPORTING. SEPSIS ALLIANCE MOBILIZED GRASSROOTS ADVOCATES THROUGH HILL DAY ACTIVITIES AND ADVOCACY ACTIONS, WHILE CONTINUING TO EDUCATE POLICYMAKERS AND STAKEHOLDERS. 240069 RESEARCH AND INNOVATIONSEPSIS ALLIANCE HOSTED ITS INAUGURAL UNITE FOR SEPSIS SYMPOSIUM IN CHICAGO IN SEPTEMBER. THE EVENT DREW MORE THAN 180 OF THE NATION'S LEADING EXPERTS FROM INDUSTRY, RESEARCH, POLICY, FUNDING, AND HEALTHCARE TO DISCUSS THE MOST PRESSING ISSUES IN SEPSIS RESEARCH AND INNOVATION. THE SUCCESS OF THIS EVENT IS LEADING TO THE 2ND ANNUAL MEETING IN WASHINGTON D.C. IN 2026. SEPSIS ALLIANCE ALSO PARTNERED WITH A BROAD NETWORK OF INDUSTRY LEADERS AND RESEARCH INSTITUTIONS TO ENGAGE SEPSIS SURVIVORS, FAMILY MEMBERS, AND HEALTHCARE PROFESSIONALS IN SHAPING CRITICAL RESEARCH AND DEVELOPMENT EFFORTS, ENSURING THAT INNOVATION IS INFORMED BY REAL-WORLD PATIENT AND CLINICAL EXPERIENCE. THESE INITIATIVES UNDERSCORE THE ORGANIZATION'S GROWING ROLE AS A CONVENER AND THOUGHT LEADER IN SEPSIS RESEARCH AND INNOVATION. 240069 2071734 1 1 0 1 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 59 0 14 1 0 0 0 0 0 0 0 0 0 0 X 19 16 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 AL AR CA CO CT DC FL GA HI IL KS MA MD MA MI MN MO NV NJ NM NY NC ND OH OK OR PA RI WA WV WI X X X THOMAS N HEYMANN 6192320300 3180 UNIVERSITY AVENUE SAN DIEGO CA 92104 X CINDY HOU CHIEF MEDICAL OFFICER 5.00 0.00 X 2125 0 0 PAT POSA DIRECTOR 1.00 0.00 X 700 0 0 KATY GRAINGER DIRECTOR 15.00 0.00 X 0 0 0 KARIN MOLANDER DIRECTOR 4.00 0.00 X 0 0 0 STEVEN SIMPSON BOARD CHAIR 18.00 0.00 X X 0 0 0 PAUL EPNER THRU 582025 VICE CHAIR 15.00 0.00 X X 0 0 0 THERESA BROWN VICE CHAIR 10.00 0.00 X X 0 0 0 JILL GRESS SECRETARY 15.00 0.00 X X 0 0 0 ERIN BORGER THRU 10825 DIRECTOR 0.00 0.00 X 0 0 0 PAUL BURTON DIRECTOR 2.00 0.00 X 0 0 0 CARL FLATLEY DIRECTOR 10.00 0.00 X 0 0 0 LUKAS HAYNES THRU 123125 DIRECTOR 6.00 0.00 X 0 0 0 CATRIONA MACDONALD DIRECTOR 2.00 0.00 X 0 0 0 WILLIAM MOONEY DIRECTOR 6.50 0.00 X 0 0 0 JIM O'BRIEN DIRECTOR 2.00 0.00 X 0 0 0 RANGARAJAN SAMPATH DIRECTOR 1.50 0.00 X 0 0 0 MARK WEINSTEIN DIRECTOR 10.00 0.00 X 0 0 0 BOBBY REDDY DIRECTOR 1.50 0.00 X 0 0 0 LAURA EVANS DIRECTOR 1.00 0.00 X 0 0 0 TIM SWEENEY DIRECTOR 1.00 0.00 X 0 0 0 VILLERS TERBLANCHE DIRECTOR 1.00 0.00 X 0 0 0 PAUL ROYLE TREASURER 2.00 0.00 X 0 0 0 THOMAS HEYMANN CHIEF EXECUTIVE OFFICER 40.00 0.00 X 306000 0 15372 SAVANNAH STARK VP DEVELOPMENT & OPERATION 40.00 0.00 X 183910 0 0 CLAUDIA A ORTH DIRECTOR OF PROVIDER EDUCA 40.00 0.00 X 130850 0 0 HANNAH SASS SENIOR PROVIDER EDUCATION & TRAINING MANAGER 40.00 0.00 X 112000 0 5938 ALLISON STRICKLAND SENIOR CLINICAL EDUCTION MANAGER 40.00 0.00 X 109000 0 0 ALEX COLVIN DIRECTOR OF MARKETING & COMMUNICATION 40.00 0.00 X 146352 0 6261 990937 0 27571 6 0 1 0 0 5568712 5568712 19345 19345 13287 6894 6393 6393 MISCELLANEOUS 900099 2777 2777 2777 5597227 6393 0 22122 X 324197 235052 53057 36088 1319171 942751 228218 148202 30792 22595 4952 3245 96561 70856 15530 10175 45322 22661 22661 105519 105519 27500 27500 306646 299016 4930 2700 71768 23648 48120 40394 23106 9632 7656 34379 27503 3438 3438 7068 4241 707 2120 174533 127013 4008 43512 51103 19478 21886 9739 DUES AND SUBSCRIPTIONS 132205 120795 576 10834 FUNDRAISING FEES 41966 41966 2809124 2071734 369595 367795 1139037 3004338 792361 957 84599 6145 6969 23314 68401 9566 9566 0 0 64020 2503 1233473 3959171 215672 141338 29000 40000 244672 181338 X 468569 3580124 520232 197709 988801 3777833 1233473 3959171 2788103 929 0 X 0 1 X 1 0 X 2231896 2380372 2180561 2506949 5568712 14868490 2231896 2380372 2180561 2506949 5568712 14868490 3731927 11136563 4073 8124 37253 29476 19345 98271 1191 1600 2807 2777 8375 14975136 104711 0.74370 0.91970 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: OTHER INCOME - 2021 AMOUNT: $ 1,191. 2022 AMOUNT: $ 1,600. 2023 AMOUNT: $ 2,807. 2025 AMOUNT: $ 2,777. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 3976 54949 58925 2008852 2067777 253389 63347 0 0 273020 287120 279400 253389 1092929 1639394 13810 110287 52905 54949 231951 68255 71780 69850 63347 273232 409848 11729 3300 3976 19005 PART I-A, LINE 1: ADVOCACY & LOBBYING ACTIVITIES: TO SERVE AS THE LEADING SEPSIS ADVOCACY ORGANIZATION AND TRUSTED EXPERT ON LEGISLATION AND PUBLIC POLICY THAT IMPROVES SEPSIS AWARENESS, EDUCATION, DIAGNOSIS, TREATMENT, AND SURVIVOR CARE. TO EDUCATE POLICYMAKERS, ADVOCATES, HEALTHCARE PROFESSIONALS, AND THE GENERAL PUBLIC ABOUT LEGISLATION, REGULATIONS, AND PUBLIC POLICIES THAT DIRECTLY IMPACT SEPSIS PATIENTS, SURVIVORS, AND LOVED ONES INCLUDING: THE NEED FOR BETTER CONNECTED SEPSIS DATA ON THE STATE AND FEDERAL LEVELS THE IMPACT OF ANTIMICROBIAL RESISTANCE ON SEPSIS AND THEIR RELATIONSHIP SEPSIS MANAGEMENT AND TREATMENT GUIDANCE AS STIPULATED BY FEDERAL REGULATORY AND CARE REIMBURSEMENT ENTITIES. 9566 9566 0 0 X 5598156 929 929 5597227 0 5597227 2809124 0 2809124 0 2809124 PART X, LINE 2: THE ORGANIZATION IS SUBJECT TO THE PROVISIONS OF THE FINANCIAL ACCOUNTING STANDARDS BOARD'S (THE "FASB") ACCOUNTING STANDARDS CODIFICATION ("ASC") TOPIC 740, INCOME TAXES, AS IT RELATES TO ACCOUNTING AND REPORTING FOR UNCERTAINTY IN INCOME TAXES. FOR THE ORGANIZATION, THESE PROVISIONS COULD BE APPLICABLE TO THE INCURRENCE OF UNRELATED BUSINESS INCOME TAX ("UBIT") ON MERCHANDISE SALES. SINCE THE ORGANIZATION HAS ALWAYS RECORDED ANY POTENTIAL TAX AND DUE TO ITS GENERAL NOT-FOR-PROFIT STATUS, MANAGEMENT BELIEVES, ASC 740 HAS NOT HAD, AND IS NOT ANTICIPATED TO HAVE, A MATERIAL IMPACT ON THE ORGANIZATION'S FINANCIAL STATEMENTS. THE ORGANIZATION RECOGNIZES BENEFITS FROM UNCERTAIN TAX POSITIONS TAKEN IN ITS INCOME TAX RETURNS WHEN THOSE TAX POSITIONS ARE MORE THAN LIKELY NOT TO BE SUSTAINED UPON EXAMINATION BY TAXING AUTHORITIES. THERE ARE NO UNRECOGNIZED TAX BENEFITS, INTEREST OR PENALTIES INCLUDED IN THE STATEMENT OF FINANCIAL POSITION OR STATEMENT OF ACTIVITIES. X X X 0 0 0 0 0 0 0 1 0 THOMAS HEYMANN CHIEF EXECUTIVE OFFICER 288776 0 17224 0 0 0 0 0 15372 0 321372 0 0 0 SAVANNAH STARK VP DEVELOPMENT & OPERATION 148547 0 35363 0 0 0 0 0 0 0 183910 0 0 0 ALEX COLVIN DIRECTOR OF MARKETING & COMMUNICATIO 124930 0 21422 0 0 0 0 0 6261 0 152613 0 0 0 PART I, LINE 7 EMPLOYEES ARE ELIGIBLE TO RECEIVE EACH CALENDAR YEAR A PERFORMANCE-BASED BONUS AS DETERMINED BY THE BOARD BASED ON THE ACHIEVEMENT OF ESTABLISHED GOALS OF THE ORGANIZATION. CATRIONA MACDONALD BOARD MEMBER 27500 LOBBYING 0 FORM 990, SCHEDULE L, PART IV, LINE 1 DURING 2025, SEPSIS ENGAGED LINCHPIN STRATEGIES LLC, OF WHICH BOARD MEMBER CATRIONA MACDONALD IS A PRESIDENT, TO CONDUCT LOBBYING ACTIVITIES FORM 990, PART VI, SECTION B, LINE 11B THE FINAL 990 IS REVIEWED AND APPROVED BY FINANCE COMMITTEE. THE 990 IS THEN SUBMITTED AFTER EVALUATING ALL COMMENTS BY THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION B, LINE 12C ANNUALLY EACH MEMBER OF THE BOARD OF DIRECTORS IS REQUIRED TO SUBMIT A SIGNED COPY OF THE CONFLICT OF INTEREST POLICY. FORM 990, PART VI, SECTION B, LINE 15 FORM 990, PART VI LINE 15A COMPENSATION PROCESS FOR TOP OFFICIAL COMPENSATION IS REVIEWED BY THE COMPENSATION COMMITTEE. COMMITTEE PREPARES RECOMMENDATIONS AND PROVIDES TO THE BOARD OF DIRECTORS. FORM 990, PART VI LINE 15B COMPENSATION PROCESS FOR OFFICERS COMPENSATION IS REVIEWED BY THE COMPENSATION COMMITTEE. COMMITTEE PREPARES RECOMMENDATIONS AND PROVIDES TO THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION C, LINE 19 DISCLOSURE OF GOVERNING DOCUMENTS, ETC. ARE PROVIDED UPON REQUEST AND APPROVAL OF THE BOARD OF DIRECTORS FOR THE SAME PERIOD OF DISCLOSURE AS SET FORTH UNDER IRC SECTION 6104(D). FORM 990, PART VI - SECTION C, LINE 17 - STATES REQUIRED TO FILE SEPSIS ALLIANCE USES LABYRINTH FOR STATE CHARITABLE FILINGS AND IN 2025 SEPSIS ALLIANCE IS REGISTERED IN ALL STATES THAT REQUIRE FILINGS. FORM 990, PART VII - COMPENSATION OF BOARD MEMBERS NO MEMBER OF THE BOARD OF DIRECTORS IS COMPENSATED FOR THEIR SERVICE TO THE ORGANIZATION AS A BOARD MEMBER. SOME BOARD MEMBERS PROVIDE SERVICES TO THE ORGANIZATION BASED ON THEIR SCIENTIFIC CREDENTIALS AS PART OF THE ORGANIZATION'S PROGRAM SERVICES. FORM 990, PART IX, LINE 11G OTHER PROFESSIONAL FEES: PROGRAM SERVICE EXPENSES 299,016. MANAGEMENT AND GENERAL EXPENSES 4,930. FUNDRAISING EXPENSES 2,700. TOTAL EXPENSES 306,646.